Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  1. Tolaney, S.M.
  2. Guarneri, V.
  3. Seo, J.H.
  4. Cruz, J.
  5. Abreu, M.H.
  6. Takahashi, M.
  7. Barrios, C.
  8. McIntyre, K.
  9. Wei, R.
  10. Munoz, M.
  11. Antonio, B.S.
  12. Liepa, A.M.
  13. Martin, M.
  14. Johnston, S.R.D.
  15. Kellokumpu-Lehtinen, P.-L.
  16. Harbeck, N.
Revista:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Ano de publicación: 2024

Volume: 199

Tipo: Artigo

DOI: 10.1016/J.EJCA.2024.113555 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus